Health TrialsbyHealthPanel

Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase I Clinical Trial of YKYY031 for Injection in Patients With Advanced Solid Tumors

Phase I study of YKYY031 for injection in patients with advanced solid tumors

Participants needed: 76
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.Updated: Oct 13, 2026Locations: 2
Eligibility criteria

Male or female patients aged 18 to 75 years old at the time of signing the infor... [+8]

Allergy to the investigational product (including any excipients). History of se... [+27]

Read more
Status: Recruiting

A Phase 1 Study to Evaluate the Safety, Reactogenicity and Immunogenicity of YKYY025 Injection

A Phase 1 Study to Evaluate the Safety, Reactogenicity and Immunogenicity of YKYY025 Injection

Participants needed: 180
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.Updated: Sep 10, 2026Locations: 1
Eligibility criteria

Male or female participants aged ≥18 to 49 years of age (Part 1) or [+4]

Previously received RSV vaccine or have participated or are currently participat... [+18]

Read more
Status: Not yet recruiting

A Phase II Clinical Study to Evaluate the Efficacy and Safety of YKYY018 for Inhalation Solution

A phase II clinical study to evaluate the efficacy and safety of YKYY018 for inhalation solution in adult participants with respiratory syncytial virus infection

Participants needed: 160
Trial details
Phase: Phase 2Age: 18-85Biological sex: AllType: InterventionalSponsor: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.Updated: Sep 8, 2026Locations: 1
Eligibility criteria

Participant must voluntarily consent to participate in this study and provide th... [+5]

At the time of screening, the patient had already been hospitalized for treatmen... [+19]

Read more
Status: Recruiting

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Profile of YKYY033 Injection

A phase 1 study to evaluate the safety and tolerability of a single administration of YKYY033 injection in healthy adult participants

Participants needed: 40
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.Updated: Aug 26, 2026Locations: 1
Eligibility criteria

Participant must voluntarily consent to participate in this study and provide th... [+2]

History or present history of clinically significant hematological, circulatory,... [+24]

Read more